Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center trial for rasburicase in children at high risk of tumor lysis syndrome
who have a history of asthma/atopy. The main purpose of this study is to establish the safety
of this drug in patients with a history of asthma or severe allergies.